diclofenac potassium · Cosette · NDA 022202
Zipsor
Earliest generic entry, as listed
24 Feb 2029
Blocked by patent: US 7662858, US 7884095, US 7939518, US 8110606, US 8623920, US 9561200. Only method-of-use patents remain, so a generic may carve out the protected indication and enter earlier.
Listed patents · 6 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 7662858 | use U-1035 | 24 Feb 2029 |
| US 7884095 | use U-1111 | 24 Feb 2029 |
| US 7939518 | use U-980 | 24 Feb 2029 |
| US 8110606 | use U-980 | 24 Feb 2029 |
| US 8623920 | use U-1482 | 24 Feb 2029 |
| US 9561200 | use U-1482 | 24 Feb 2029 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 022202 · 001 · RLD | capsule, oral | 25MG | 24 Feb 2029 |